To investigate whether interfering with REG4 expression would affect tumor ability to evade immune system, we inactivated REG4 gene in type I MSS CRC immunotherapy-resistant PDO model with high REG4 expression (Supplementary Fig. S5A) using small guide RNA (sgRNA) pairs designed to delete the transcription start site. Here, REG4 is linked to neoplasm.